Sigal Kalmanson Cusnir

Sigal Kalmanson Cusnir is the CEO and Co-Founder of Starget Pharma, an early-stage clinical company developing a new class of Smart Targeted Radioligands for precision oncology. She is a seasoned executive manager and serial entrepreneur with extensive business and management experience in global companies and startups. Kalmanson Cusnir has a background in marketing, strategy, and business operations, previously holding a VP position at Microsoft Israel and leadership roles at Comverse. She has also been a co-founder and investor in several technology startup companies and worked as a strategy consultant for pharma and hi-tech companies. She was recognized as one of the 40 most promising Israeli managers under 40 by Globes magazine.